Risedronate to Prevent Skeletal Related Events in Patients With Metastatic Prostate Cancer Commencing Hormonal Therapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Christopher Sweeney, M.B.B.S.
Hoosier Oncology Group, LLC
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
45 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Southern Interior Medical Research, Inc.
Kelowna, British Columbia, Canada
- Andreou Research
Surrey, British Columbia, Canada
- Dr. G. Steinhoff Clinical Research
Victoria, British Columbia, Canada
- Dr. Allan Patrick Professional Corporation
Fredericton, New Brunswick, Canada
- Male/female Health and Research
Barrie, Ontario, Canada
- Burlington Professional Centre
Burlington, Ontario, Canada
- Urology Resource Centre
Burlington, Ontario, Canada
- Hamilton District Urology Research Center
Hamilton, Ontario, Canada
- Centre for Advanced Urological Research
Kingston, Ontario, Canada
- London Region Cancer Program
London, Ontario, Canada
- Mor Urology, Inc.
Newmarket, Ontario, Canada
- Male Health Centres
Oakville, Ontario, Canada
- Scarborough General Hospital, Medical Mall
Scarborough Village, Ontario, Canada
- University Health Network - Princess Margaret Division
Toronto, Ontario, Canada
- Center for Urological Research
La Mesa, California, United States
- San Bernadino Urological Associates
San Bernardino, California, United States
- Grove Hill Medical Center Urology
New Britain, Connecticut, United States
- Innovative Surgical Resources
Tampa, Florida, United States
- Medical & Surgical Specialists, Llc
Galesburg, Illinois, United States
- Peoria Urological Associates
Peoria, Illinois, United States
- Oncology Hematology Associates of Sw Indiana
Evansville, Indiana, United States
- Center for Cancer Care at Goshen Health System
Goshen, Indiana, United States
- Indiana University Cancer Center
Indianapolis, Indiana, United States
- Quality Cancer Center (mcgop)
Indianapolis, Indiana, United States
- Urology of Indiana, Llc
Indianapolis, Indiana, United States
- Urology Associates
Muncie, Indiana, United States
- Northern Indiana Cancer Research Consortium
South Bend, Indiana, United States
- Urologic Surgery Associates
Baltimore, Maryland, United States
- Drs. Werner, Murdock and Francis Pa Urology Associates
Greenbelt, Maryland, United States
- Mayo Clinic Rochester
Rochester, Minnesota, United States
- Kansas City Urology Care
Kansas City, Missouri, United States
- Siteman Cancer Center
St Louis, Missouri, United States
- Nevada Urology
Reno, Nevada, United States
- Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
- Lawrenceville Urology
Trenton, New Jersey, United States
- Accumed Research Associates
Garden City, New York, United States
- Staten Island Urological Research, P.C.
Staten Island, New York, United States
- Cleveland Clinic Foundation
Cleveland, Ohio, United States
- Oregon Urology Specialists
Springfield, Oregon, United States
- Urological Associates of Lancaster
Lancaster, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2003
- Primary completion
- 29 Feb 2008
- Completion
- 31 Mar 2008
- Last update posted
- 26 May 2016
- Registered enrollment
- 63
- Registry id
- NCT00216060
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.